The recommendations (adopted in December 1997) for the production of tallow derivatives for use in pharmaceuticals (CPMP/ BWP/ 1163/ 97), as well as the recommendations for gelatine use in pharmaceuticals, were incorporated into the proposed revision of the ‘ TSE guideline’.